Read + Share
Amedeo Smart
Independent Medical Education
Ganguly S, Gogia A. Rucaparib for recurrent ovarian cancer with BRCA1 and BRCA2 mutations. Lancet Oncol 2022;23:e314.PMID: 35772456
Email
LinkedIn
Facebook
Twitter
Privacy Policy